ICBI Companies

AccelerateRX Labs

Developing new therapies for pain and traumatic brain injury to be used in the community, in the hospital and in response to the threat of Opioid Induced Respiratory Depression in terrorism.

CARDIOBIOPHARMA is a specialized contract research organization that provides expert consultation and fee for service for testing novel compounds and proteins on heart function or toxicity. The primary assays are the rodent heart organ bath systems known as Langendorff and working heart.

Degrome Therapeutics, Inc. is specialized in discovery and development of small molecule degraders of neurodegenerative disease-causing proteins as the first-in-class drugs. The company was founded by Drs. Anita Bellail and Chunhai Hao in 2023 in Indiana after they identified hit compounds as Alzheimer Precursor Protein (APP) degrader.

E&E BioClub focuses on facilitating the advancement of biotherapeutics into the clinical stage by developing cost-effective and scalable manufacturing processes.

Discovery and development of small molecule protein degraders as new anticancer drugs.

Stephen Skolnick and Company is harnessing the power of the human gut microbiome to produce new and innovative foods for human health.

Treatment of vascular complications.